Skip to content

Moxibustion alleviated Irritable bowel syndrome by modulating gut microbiota composition and metabolic profiles

Moxibustion alleviated Irritable bowel syndrome by modulating gut microbiota composition and metabolic profiles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115188
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-06-07
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBS

Interventions

Control group:Simulated Moxibustion
Intervention group:Umbilical Moxibustion Group

Sponsors

The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. IBS patients meeting Rome IV criteria (abdominal pain = times per week for the past 3 months, accompanied by altered stool frequency or consistency); 2. Age: 18–65 years old, no gender restrictions; 3. IBS Symptom Severity Scale (IBS-SSS) score >= 175 points (moderate and above); 4. Voluntary informed consent;

Exclusion criteria

Exclusion criteria: 1. Organic diseases including ulcerative colitis, intestinal polyps, and gastrointestinal tumours; 2. Use of antibiotics, probiotics, immunosuppressants or antidepressants within the past month; 3. Severe abnormalities in cardiac, hepatic or renal function; psychiatric disorders or cognitive impairment; 4. Pregnant women, breastfeeding women, or those planning to conceive within the next three months; 5. Individuals with umbilical skin lesions or allergies to moxa wool;

Design outcomes

Primary

MeasureTime frame
IBS-SSS;

Secondary

MeasureTime frame
SAS/SDS scales;Fecal 16S Sequencing;Non-targeted urine metabolomics;Bristol Stool Scale;IBS-QOL;

Countries

China

Contacts

Public Contactliu Qingqing

The Fourth Affiliated Hospital, Zhejiang University School of Medicine

549066957@163.com+86 579 8993 5709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026